<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02423109</url>
  </required_header>
  <id_info>
    <org_study_id>CV-15-13</org_study_id>
    <nct_id>NCT02423109</nct_id>
  </id_info>
  <brief_title>Bilateral Dispensing Study of Fanfilcon A Toric Versus Enfilcon A Toric Lenses</brief_title>
  <official_title>Bilateral Dispensing Study of Fanfilcon A Toric Versus Enfilcon A Toric Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coopervision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coopervision, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bilateral dispensing clinical trial of fanfilcon A toric lens verses enfilcon A toric lens
      over two weeks.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evaluation of the clinical performance of an investigational silicone-hydrogel lens called
      fanfilcon A (test) compared to a FDA-cleared commercially available contact lens called
      enfilcon A toric lens (control) when worn on a daily wear basis over 2 weeks in a randomized,
      bilateral, cross-over, dispensing study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comfort (Subjective Rating Scale)</measure>
    <time_frame>Dispensing (Baseline) and 2 weeks</time_frame>
    <description>Participant rating for comfort at dispense visit and at the 2 week follow-up on a subjective rating scale (0-100, 0=cannot be worn. Causes pain,100=Cannot be felt ever)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comfort Preference</measure>
    <time_frame>Dispensing (Baseline) and 2 weeks</time_frame>
    <description>Subjective assessment for comfort preference for each lens pair. Choices: fanfilcon A lens, enfilcon A lens, No preference.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Myopia</condition>
  <condition>Hyperopia</condition>
  <condition>Astigmatism</condition>
  <arm_group>
    <arm_group_label>fanfilcon A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each subject randomized to wear either the test or control as a matched pair and cross over to the second matched pair.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>enfilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each subject randomized to wear either the test or control as a matched pair and cross over to the second matched pair.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>fanfilcon A</intervention_name>
    <description>contact lens</description>
    <arm_group_label>fanfilcon A</arm_group_label>
    <arm_group_label>enfilcon A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>enfilcon A</intervention_name>
    <description>contact lens</description>
    <arm_group_label>fanfilcon A</arm_group_label>
    <arm_group_label>enfilcon A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Are at least 17 years of age for Canada and 18 years of age for the USA and have full
             legal capacity to volunteer;

          -  Have read and signed an information consent letter;

          -  Are willing and able to follow instructions and maintain the appointment schedule;

          -  Are an adapted soft contact lens wearer;

          -  Require spectacle lens powers in both eyes;

               -  Sphere: between -0.50 to -6.00 diopters and

               -  Astigmatism: between -1.25 to -2.00 and

               -  Axis: 180 Â± 20 degrees

          -  Are willing to wear contact lens in both eyes;

          -  Have manifest refraction visual acuities (VA) equal to or better than logMAR
             equivalent of 20/25 in each eye;

          -  To be eligible for lens dispensing, the subject must have VA of logMAR equivalent of
             20/30 or better in each eye with the study lenses and the investigator must judge the
             fit including toric orientation as acceptable;

        Exclusion Criteria:

          -  Are participating in any concurrent clinical or research study;

          -  Have any known active* ocular disease and/or infection;

          -  Have a systemic condition that in the opinion of the investigator may affect a study
             outcome variable;

          -  Are using any systemic or topical medications that in the opinion of the investigator
             may affect a study outcome variable;

          -  Have known sensitivity to the diagnostic pharmaceuticals to be used in the study;

          -  Are pregnant, lactating or planning a pregnancy at the time of enrolment (by verbal
             confirmation at the screening visit);

          -  Are aphakic;

          -  Have undergone refractive error surgery;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Meng Lin, OD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Research Center, University of California, Berkeley</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lyndon Jones, PhD FCO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Center for Contact Lens Research, University of Waterloo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinical Research Center, University of California, Berkeley</name>
      <address>
        <city>Berkeley</city>
        <state>California</state>
        <zip>94704</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center for Contact Lens Research, University of Waterloo</name>
      <address>
        <city>Waterloo</city>
        <state>Ontario</state>
        <zip>N2L 3G1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 17, 2015</study_first_submitted>
  <study_first_submitted_qc>April 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 22, 2015</study_first_posted>
  <results_first_submitted>November 8, 2017</results_first_submitted>
  <results_first_submitted_qc>January 8, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">January 10, 2018</results_first_posted>
  <disposition_first_submitted>September 29, 2017</disposition_first_submitted>
  <disposition_first_submitted_qc>October 16, 2017</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">October 18, 2017</disposition_first_posted>
  <last_update_submitted>January 8, 2018</last_update_submitted>
  <last_update_submitted_qc>January 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Astigmatism</mesh_term>
    <mesh_term>Hyperopia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>44 subjects were enrolled (assigned an ID per protocol), but 11 were not assigned to any group due to screen failure.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Randomized for Fanfilcon A Lens First, Then Enfilcon A Lens</title>
          <description>Each subject randomized to wear either the test or control as a matched pair and cross over to the second matched pair.
fanfilcon A: toric contact lens enfilcon A: toric contact lens</description>
        </group>
        <group group_id="P2">
          <title>Randomized for Enfilcon A Lens First, Then Fanfilcon A Lens</title>
          <description>Each subject randomized to wear either the test or control as a matched pair and cross over to the second matched pair.
fanfilcon A: toric contact lens enfilcon A: toric contact lens</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Lens 1</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Lens 2</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Includes the 11 participants who were considered enrolled, but were screen failures and not randomly assigned to a particular arm.</population>
      <group_list>
        <group group_id="B1">
          <title>Overall Study</title>
          <description>All subjects were wore both fanfilcon A and enfilcon A toric lenses as either the first or second intervention.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="44"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Comfort (Subjective Rating Scale)</title>
        <description>Participant rating for comfort at dispense visit and at the 2 week follow-up on a subjective rating scale (0-100, 0=cannot be worn. Causes pain,100=Cannot be felt ever)</description>
        <time_frame>Dispensing (Baseline) and 2 weeks</time_frame>
        <population>Analysis population differs slightly due to 1 participant who was excluded from analysis due to a protocol deviation.</population>
        <group_list>
          <group group_id="O1">
            <title>Fanfilcon A</title>
            <description>All participants who wore fanfilcon A lens pair randomly assigned as first or second pair.
fanfilcon A: contact lens</description>
          </group>
          <group group_id="O2">
            <title>Enfilcon A</title>
            <description>All participants who wore enfilcon A lens pair randomly assigned as first or second pair.
enfilcon A: contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Comfort (Subjective Rating Scale)</title>
          <description>Participant rating for comfort at dispense visit and at the 2 week follow-up on a subjective rating scale (0-100, 0=cannot be worn. Causes pain,100=Cannot be felt ever)</description>
          <population>Analysis population differs slightly due to 1 participant who was excluded from analysis due to a protocol deviation.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Dispensing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87" spread="17"/>
                    <measurement group_id="O2" value="88" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 week</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79" spread="15"/>
                    <measurement group_id="O2" value="76" spread="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Comfort Preference</title>
        <description>Subjective assessment for comfort preference for each lens pair. Choices: fanfilcon A lens, enfilcon A lens, No preference.</description>
        <time_frame>Dispensing (Baseline) and 2 weeks</time_frame>
        <population>Analysis population differs slightly due to protocol deviation.</population>
        <group_list>
          <group group_id="O1">
            <title>Overall Study - Dispense</title>
            <description>Each subject randomized to wear either the test or control as a matched pair and cross over to the second matched pair.
fanfilcon A: contact lens
enfilcon A: contact lens</description>
          </group>
          <group group_id="O2">
            <title>Overall Study - Follow Up</title>
            <description>Each subject randomized to wear either the test or control as a matched pair and cross over to the second matched pair.
fanfilcon A: contact lens
enfilcon A: contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Comfort Preference</title>
          <description>Subjective assessment for comfort preference for each lens pair. Choices: fanfilcon A lens, enfilcon A lens, No preference.</description>
          <population>Analysis population differs slightly due to protocol deviation.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>fanfilcon A</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>enfilcon A</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No Preference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data were collected through the duration of the study (2 weeks for each lens).</time_frame>
      <desc>Adverse events data was collected during the follow-up visits and until the subject exited the study.</desc>
      <group_list>
        <group group_id="E1">
          <title>Fanfilcon A</title>
          <description>Participants randomized to wear fanfilcon A either as the first or second lens during the cross over study.</description>
        </group>
        <group group_id="E2">
          <title>Enfilcon A</title>
          <description>Participants randomized to wear enfilcon A either as the first or second lens during the cross over study.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Disclosure restriction on the PI is that the sponsor should be notified of any results communications and has ability to review.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Myhanh Nguyen, OD</name_or_title>
      <organization>CooperVision</organization>
      <phone>9257306716</phone>
      <email>mnguyen@coopervision.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

